In a Series A fundraising round headed by Vertex Ventures, Spyne, an AI-powered visual marketing platform for the automobile ...

The new funding will enable the company to enhance its AI-powered platform, strengthen its technology infrastructure, and expand into new international markets, including high-growth regions across ...

The latest funding round saw participation from Siana Capital, Callapina Capital, Z21 Ventures, 1Crowd, LetsVenture, and ...

The Protein Sequencing Companytm, and several distinguished researchers will be presenting new research and applications at the 2025 Advances in Genome Biology and Technology ...

Santos (ASX:STO), the mammoth gas producer, tumbled by 5% and dragged down the sector after its full-year profit slumped 14%, ...

Atomwise, a leader in leveraging machine learning and artificial intelligence (ML/AI) to advance small molecule drug discovery, today announced the appointment of Steve Worland, Ph.D. as Chief ...

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

At a time when many life sciences companies are shrinking their workforce, Vertex Pharmaceuticals Inc. has once again grown ...

Morgan Stanley analyst Terence Flynn maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of $145.00.

The ASX took a hit as Trump’s tariff threat rattled markets, while NAB's earnings miss saw its stock tank, adding to the unease.

By Ayanna Eckblad For over 35 years Chiropractic Clinic has served the community, helping their patients treat a variety of different conditions and helping them live a better quality of life. The ...

In the midst of severe weather, Kentucky Governor Andy Beshear has signed an executive order allowing pharmacists to dispense ...